|
1/08/21
|
Graymark Capital acquired a vacant, single-story office/R&D asset in Palo Alto. The property was recently vacated by a medical device company building a digital surgery platform.
The two-building, 24k sf complex is located at 3960-3980 Fabian Way. Graymark plans to reposition the property as Life Sciences-focused with a flexible design to equally accommodate emerging sectors such as Automotive Tech, Food Tech and/or Robotics/Artificial Intelligence. The company will implement a multi-million dollar capital investment to complete the conversion.
3960-3980 Fabian Way is surrounded by amenities, food service and fitness/health facilities. The property also provides convenient access to Highway 101, Alma/Central Expressway and transportation services including Caltrain.
Kalil Jenab, Ben Paul and Steven Jenab with Cushman & Wakefield represented the buyer in the acquisition and have also been retained to provide leasing services for the newly designed project. The seller was repped by Brad Martin with Stetson Earhart.
“Palo Alto and the surrounding Peninsula area have been a hot bed for Life Sciences activity, with the three largest such Bay Area deals in 2020 all located within just a few miles of this subject property,” noted Jenab. “The Fabian buildings reside within this vigorous cluster of highly influential global tech and life sciences users and world class developers accelerating the improvement in this submarket.”
|
|
Return to the Archive page
|
|
|
|
|